Status:
COMPLETED
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This observational study will assess the median time of treatment duration and the safety of Avastin (bevacizumab) as first line treatment in patients with metastatic breast cancer. Data will be colle...
Eligibility Criteria
Inclusion
- Patients with metastatic breast cancer in first line treatment who have completed treatment with Avastin
Exclusion
- Patients not willing or unable to signed written consent form
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01215123
Start Date
January 1 2010
End Date
July 1 2012
Last Update
February 22 2016
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Buenos Aires, Argentina, B1708EIL
2
Buenos Aires, Argentina, C1113AAC
3
Buenos Aires, Argentina, C1116ABC
4
Buenos Aires, Argentina, C1199ACI